Vestcor Inc Boosts Holdings in Astera Labs, Inc. $ALAB

Vestcor Inc grew its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 244.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,784 shares of the company’s stock after buying an additional 2,684 shares during the period. Vestcor Inc’s holdings in Astera Labs were worth $630,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in ALAB. Vanguard Group Inc. raised its holdings in shares of Astera Labs by 14.1% in the third quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock worth $2,690,907,000 after buying an additional 1,693,918 shares during the last quarter. Amundi raised its holdings in shares of Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after buying an additional 1,319,643 shares during the last quarter. Rafferty Asset Management LLC purchased a new position in shares of Astera Labs in the third quarter worth $209,599,000. BNP Paribas Financial Markets raised its holdings in shares of Astera Labs by 577.3% in the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock worth $220,733,000 after buying an additional 960,899 shares during the last quarter. Finally, Goldman Sachs Group Inc. raised its holdings in shares of Astera Labs by 189.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock worth $218,419,000 after buying an additional 858,693 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the transaction, the chief operating officer owned 5,064,213 shares in the company, valued at approximately $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the transaction, the director owned 319,863 shares of the company’s stock, valued at $34,420,457.43. The trade was a 36.39% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 2,321,256 shares of company stock worth $480,893,146. Insiders own 10.40% of the company’s stock.

Astera Labs Stock Performance

NASDAQ ALAB opened at $346.33 on Tuesday. The stock has a 50-day simple moving average of $217.60 and a two-hundred day simple moving average of $173.27. The firm has a market capitalization of $59.36 billion, a P/E ratio of 234.01, a PEG ratio of 4.20 and a beta of 3.94. Astera Labs, Inc. has a fifty-two week low of $84.78 and a fifty-two week high of $372.37.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company’s revenue was up 93.5% on a year-over-year basis. During the same quarter last year, the business posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Analysts Set New Price Targets

ALAB has been the subject of a number of research analyst reports. Evercore reaffirmed an “outperform” rating and issued a $297.00 price target on shares of Astera Labs in a report on Tuesday, May 19th. Susquehanna raised their price target on shares of Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th. JPMorgan Chase & Co. raised their price target on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $270.00 price target on shares of Astera Labs in a report on Wednesday, May 6th. Finally, Roth Mkm reaffirmed a “buy” rating and issued a $275.00 price target on shares of Astera Labs in a report on Wednesday, May 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and an average price target of $233.75.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.